ProfileGDS5822 / ILMN_2782503
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 98% 98% 97% 98% 98% 98% 99% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1284498
GSM1276600PDAC Late Ablation Control 22884.898
GSM1276601PDAC Late Ablation Control 3246397
GSM1276602PDAC Late Ablation 12604.698
GSM1276603PDAC Late Ablation 23235.998
GSM1276604PDAC Late Ablation 33861.798
GSM1303940PDAC Late Ablation_anti-CTLA4 14604.599
GSM1303941PDAC Late Ablation_anti-CTLA4 23625.998
GSM1303942PDAC Late Ablation_anti-CTLA4 33040.498